GSA Capital Partners’s Aclaris Therapeutics ACRS Stock Holding History

GSA Capital Partners’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$67K	Buy
2025 Q1	$47K	Buy
2024 Q4	–	Sell
2024 Q3	$293K	Sell
2024 Q2	$370K	Sell
2024 Q1	$842K	Sell
2023 Q4	$1.67M	Buy
2023 Q3	$260K	Sell
2023 Q2	$865K	Buy
2023 Q1	$262K	Buy